EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$1.12
+0.00 (+0.00%)
As of Feb 8, 2:29 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,591.1% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $1.12
Current
$1.12
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
1,916.1%
Low target
Base Case
$30.14
+2,591.1%
Avg target
Bull Case
$41.69
+3,622.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$35.24
-96.8% from high
52-Week Low
$24.14
+-95.4% from low
Target vs 52W High
$30.14
-14.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%